Skip to Main Content

Author Details

Nazim Benzerdjeb
Institut de Pathologie Multisite
2013
56
14
PMIDPaper TitleJournal TitlePublished Year
36822899[Differential diagnostic between hepatocellular carcinoma and hepatoid carcinoma with bone metastasis revelation: What tools can be used?]Ann Pathol2023
37627320Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling.Biomolecules2023
37835560Molecular Characterization of Primary Mediastinal Large B-Cell Lymphomas.Cancers (Basel)2023
37400263Temporal Bone Histopathology Case of the Month: 45S5 Bioactive Glass and Cholesteatoma.Otol Neurotol2023
37359928Primary Peritoneal Hepatoid Adenocarcinoma Patients Treated by Complete Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).Indian J Surg Oncol2023
36884158ASO Visual Abstract: Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases.Ann Surg Oncol2023
36882569ASO Visual Abstract: Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes - A Retrospective Study.Ann Surg Oncol2023
36805191Nasal fossa tumor.Eur Ann Otorhinolaryngol Head Neck Dis2023
36633865Prone position decreases acute lung inflammation measured by [<sup>11</sup>C](R)-PK11195 positron emission tomography in experimental acute respiratory distress syndrome.J Appl Physiol (1985)2023
36864324Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases.Ann Surg Oncol2023
36729351Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes: A Retrospective Study.Ann Surg Oncol2023
34713369Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study.Ann Surg Oncol2022
35406395High Keratin-7 Expression in Benign Peri-Tumoral Prostatic Glands Is Predictive of Bone Metastasis Onset and Prostate Cancer-Specific Mortality.Cancers (Basel)2022
35703957Colorectal Liver Micrometastases: Association with RAS/TP53 Co-Mutation and Prognosis after Surgery.J Am Coll Surg2022
355759355-hmC loss is another useful tool in addition to BAP1 and MTAP immunostains to distinguish diffuse malignant peritoneal mesothelioma from reactive mesothelial hyperplasia in peritoneal cytology cell-blocks and biopsies.Virchows Arch2022
36718140Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC.JTO Clin Res Rep2022
36071285Advances in the management of peritoneal malignancies.Nat Rev Clin Oncol2022
36139595Scalloping of the Liver and Spleen on Preoperative CT-Scan of Pseudomyxoma Peritonei Patients: Impact on Prediction of Resectability, Grade, Morbidity and Survival.Cancers (Basel)2022
36038429[Rosai-Dorfman-Destombes disease with a misleading laryngeal presentation].Ann Pathol2022
36077622Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of Concept.Cancers (Basel)2022
35129652Non-invasive quantification of acute macrophagic lung inflammation with [<sup>11</sup>C](R)-PK11195 using a three-tissue compartment kinetic model in experimental acute respiratory distress syndrome.Eur J Nucl Med Mol Imaging2022
33071172Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications.Eur J Surg Oncol2021
33545255Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.Radiother Oncol2021
33560536Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status.Histopathology2021
33496472Implications of Pathologic Findings in Cytoreductive Surgery Specimens on Treatment of Colorectal Peritoneal Metastases: Results of a Prospective Multicentric Study.Dis Colon Rectum2021
34498666Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study).Br J Surg2021
34698448Feasibility and performance of the Idyllaâ¿¢ NRAS/BRAF cartridge mutation assay on thyroid liquid-based fine-needle aspiration.Diagn Cytopathol2021
34743445Dimensional reduction based on peak fitting of Raman micro spectroscopy data improves detection of prostate cancer in tissue specimens.J Biomed Opt2021
33994058Functional outcomes of soft palate free flap reconstruction following oropharyngeal cancer surgery.Eur J Surg Oncol2021
34039244Multicystic peritoneal mesothelioma treated with cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort.Int J Hyperthermia2021
34065942Orai3-Mediates Cisplatin-Resistance in Non-Small Cell Lung Cancer Cells by Enriching Cancer Stem Cell Population through PI3K/AKT Pathway.Cancers (Basel)2021
34169365Combined grade and nuclear grade are prognosis predictors of epithelioid malignant peritoneal mesothelioma: a multi-institutional retrospective study.Virchows Arch2021
34111704Longitudinal assessment of PD-L1 expression and gene expression profiles in patients with head and neck cancer reveals temporal heterogeneity.Oral Oncol2021
34226220Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: study protocol of a prospective, multicentre, observational study.BMJ Open2021
33211229ASO Author Reflections: Potential Therapeutic Implications and Prediction of Pathological Complete Response to Systemic Chemotherapy in Colorectal Peritoneal Metastases.Ann Surg Oncol2021
33210270Clinical and Radiologic Predictors of a Pathologic Complete Response to Neoadjuvant Chemotherapy (NACT) in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases: Results of a Prospective Multi-center Study.Ann Surg Oncol2021
31368077A Novel ALK-THBS1 Fusion in a Laryngeal Inflammatory Myofibroblastic Tumour: A Case Report and Literature Review.Head Neck Pathol2020
32060943Prognostic impact of combined progression index based on peritoneal grading regression score and peritoneal cytology in peritoneal metastasis.Histopathology2020
31757660Target region resection in patients undergoing cytoreductive surgery for peritoneal metastases-is it necessary in absence of visible disease?Eur J Surg Oncol2020
32040698The Pathologic Peritoneal Cancer Index (PCI) Strongly Differs From the Surgical PCI in Peritoneal Metastases Arising From Various Primary Tumors.Ann Surg Oncol2020
32940414Prospective correlation of the radiological, surgical and pathological findings in patients undergoing cytoreductive surgery for colorectal peritoneal metastases: implications for the preoperative estimation of the peritoneal cancer index.Colorectal Dis2020
32797086Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.PLoS Med2020
32618618Risk of Omental Metastases in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases.Dis Colon Rectum2020
31463946Poorly differentiated neuroendocrine carcinoma of the head and neck: human papillomavirus tumour status/p16 status and impact on overall survival.Histopathology2020
31169472Noninvasive quantification of macrophagic lung recruitment during experimental ventilation-induced lung injury.J Appl Physiol (1985)2019
31337527Pathological assessment of cytoreductive surgery specimens and its unexplored prognostic potential-a prospective multi-centric study.Eur J Surg Oncol2019
31018850Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate.Radiat Oncol2019
30824316[Diagnostic challenge of biphenotypic sinonasal sarcoma].Ann Pathol2019
29603326The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer-specific survival.Prostate2018
27995675GLUT1: A novel tool reflecting proliferative activity of lung neuroendocrine tumors?Pathol Int2017
  • 1 - 50 of 56

Recommended Authors

Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2015
Number of shared co-authors 0
Northern Hospital
Career Start Year 2012
Number of shared co-authors 1
Henry Ford Hospital
Career Start Year 2011
Number of shared co-authors 1
Singapore General Hospital
Career Start Year 2010
Number of shared co-authors 1
Western University
Career Start Year 2009
Number of shared co-authors 2
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea
Career Start Year 2008
Number of shared co-authors 0
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year 2008
Number of shared co-authors 1
INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 0
Oslo University Hospital
Career Start Year 2007
Number of shared co-authors 0
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 0
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 0
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 1
University of Toronto
Career Start Year 2003
Number of shared co-authors 2
Peking University Cancer Hospital & Institute
Career Start Year 2002
Number of shared co-authors 0
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 0
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 0
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Career Start Year 2000
Number of shared co-authors 1
University of British Columbia
Career Start Year 2000
Number of shared co-authors 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1999
Number of shared co-authors 0
Yamagata Prefectural Central Hospital
Career Start Year 1998
Number of shared co-authors 1
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year 1997
Number of shared co-authors 0
St Vincent's Hospital
Career Start Year 1997
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 0
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 1
University of Southern California
Career Start Year 1995
Number of shared co-authors 0
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Institute of Pathology, Heidelberg University Hospital
Career Start Year 1991
Number of shared co-authors 0
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0

Collaborators

Institut du cancer de Montreal
Co-authored papers 5
University of Montreal Health Center
Co-authored papers 5
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 4
Centre Hospitalier de l'Universite de Montreal
Co-authored papers 4
Centre de recherche sur le cancer de l'Universite Laval
Co-authored papers 4
CHU de Quebec-Universite Laval
Co-authored papers 4
Centre hospitalier de l'Universite de Montreal
Co-authored papers 4
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 3
Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM)
Co-authored papers 3
INSERM UMR_S9 and Universite de Strasbourg, Institut d'immunologie et d'hematologie
Co-authored papers 2
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Co-authored papers 2
Institut du Cancer de Montreal
Co-authored papers 2
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 2
University Health Network, University of Toronto
Co-authored papers 2
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 2
Centre de recherche du Centre Hospitalier de l'Universite de Montreal
Co-authored papers 2
University of Toronto
Co-authored papers 2
University of California los angeles
Co-authored papers 2
University of Toronto
Co-authored papers 2
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Centre de recherche du Centre hospitalier universitaire de Quebec-Universite Laval
Co-authored papers 2
Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM)
Co-authored papers 1
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Co-authored papers 1
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 1
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 1
Co-authored papers 1
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 1
UT Southwestern Medical Center
Co-authored papers 1
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 1